Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson 2017. BiTE® bystander T cell-dependent cellular cytotoxicity (TDCC) assay. protocols.io https://dx.doi.org/10.17504/protocols.io.hwfb7bnCopy Citation Copied
URL: https://dx.doi.org/DOI:10.17504/protocols.io.hwfb7bn
Authors: Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson
Summary: Protocol for detecting bystander cytotoxicity in mixed cultures of target-negative and target-positive cells treated with BiTE® antibody constructs. Two methods and one modification are described.
Associated Publications: Ross SL, Sherman M, McElroy PL, Lofgren JA, Moody G, Baeuerle PA, Coxon A, Arvedson T, Bispecific T cell engager (BiTE) antibody constructs can mediate bystander tumor cell killing. PLoS ONE 12(8). doi: 10.1371/journal.pone.0183390
Affiliations: Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc., Department of Oncology Research, Amgen Inc.
External URL: https://doi.org/10.1371/journal.pone.0183390
Version: 1
Publication Date: 2017
Expand AllComing soon.
Source: